中外製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/04/23 | 5,115 | 5,215 | 5,088 | 5,185 | +35 | +0.7% | 2,322,000 |
2024/04/22 | 4,991 | 5,160 | 4,946 | 5,150 | +229 | +4.7% | 2,610,900 |
2024/04/19 | 5,091 | 5,101 | 4,896 | 4,921 | -169 | -3.3% | 3,141,300 |
2024/04/18 | 5,038 | 5,096 | 4,997 | 5,090 | +25 | +0.5% | 2,472,600 |
2024/04/17 | 5,111 | 5,124 | 5,038 | 5,065 | -66 | -1.3% | 2,022,700 |
2024/04/16 | 4,988 | 5,138 | 4,960 | 5,131 | +26 | +0.5% | 2,484,100 |
2024/04/15 | 5,137 | 5,155 | 5,057 | 5,105 | -132 | -2.5% | 2,078,300 |
2024/04/12 | 5,227 | 5,257 | 5,163 | 5,237 | ±0 | ±0% | 2,919,000 |
2024/04/11 | 5,165 | 5,251 | 5,145 | 5,237 | +1 | ±0% | 2,078,700 |
2024/04/10 | 5,346 | 5,380 | 5,208 | 5,236 | -162 | -3% | 2,426,900 |
2024/04/09 | 5,420 | 5,432 | 5,354 | 5,398 | +3 | +0.1% | 2,142,700 |
2024/04/08 | 5,481 | 5,482 | 5,359 | 5,395 | -41 | -0.8% | 1,723,500 |
2024/04/05 | 5,524 | 5,555 | 5,433 | 5,436 | -135 | -2.4% | 1,971,600 |
2024/04/04 | 5,621 | 5,668 | 5,571 | 5,571 | -1 | ±0% | 2,360,800 |
2024/04/03 | 5,554 | 5,641 | 5,488 | 5,572 | +9 | +0.2% | 1,864,400 |
2024/04/02 | 5,662 | 5,690 | 5,541 | 5,563 | -131 | -2.3% | 2,557,000 |
2024/04/01 | 5,832 | 5,845 | 5,623 | 5,694 | -80 | -1.4% | 1,554,400 |
2024/03/29 | 5,780 | 5,844 | 5,742 | 5,774 | +8 | +0.1% | 2,814,500 |
2024/03/28 | 5,850 | 5,925 | 5,766 | 5,766 | -161 | -2.7% | 2,396,900 |
2024/03/27 | 5,911 | 5,985 | 5,862 | 5,927 | -12 | -0.2% | 2,716,800 |
2024/03/26 | 5,752 | 5,970 | 5,720 | 5,939 | +89 | +1.5% | 2,473,700 |
2024/03/25 | 5,910 | 5,910 | 5,811 | 5,850 | -31 | -0.5% | 2,178,700 |
2024/03/22 | 5,964 | 5,973 | 5,844 | 5,881 | -219 | -3.6% | 3,559,200 |
2024/03/21 | 6,147 | 6,153 | 6,000 | 6,100 | +40 | +0.7% | 3,096,800 |
2024/03/19 | 6,050 | 6,110 | 5,910 | 6,060 | -85 | -1.4% | 2,615,000 |
2024/03/18 | 6,010 | 6,261 | 5,996 | 6,145 | +164 | +2.7% | 2,872,100 |
2024/03/15 | 6,022 | 6,102 | 5,943 | 5,981 | -126 | -2.1% | 3,292,000 |
2024/03/14 | 6,146 | 6,197 | 6,030 | 6,107 | -112 | -1.8% | 2,560,300 |
2024/03/13 | 6,404 | 6,423 | 6,213 | 6,219 | -204 | -3.2% | 2,176,000 |
2024/03/12 | 6,430 | 6,453 | 6,380 | 6,423 | -90 | -1.4% | 2,352,700 |
2024/03/11 | 6,532 | 6,697 | 6,409 | 6,513 | -5 | -0.1% | 2,514,900 |
2024/03/08 | 6,488 | 6,573 | 6,372 | 6,518 | +83 | +1.3% | 3,827,800 |
2024/03/07 | 6,435 | 6,547 | 6,392 | 6,435 | +46 | +0.7% | 2,175,600 |
2024/03/06 | 6,317 | 6,409 | 6,254 | 6,389 | +72 | +1.1% | 2,186,800 |
2024/03/05 | 6,271 | 6,326 | 6,208 | 6,317 | +45 | +0.7% | 2,164,300 |
2024/03/04 | 6,200 | 6,283 | 6,150 | 6,272 | +163 | +2.7% | 1,921,200 |
2024/03/01 | 5,932 | 6,139 | 5,920 | 6,109 | +109 | +1.8% | 1,790,300 |
2024/02/29 | 5,901 | 6,012 | 5,886 | 6,000 | +43 | +0.7% | 2,401,300 |
2024/02/28 | 5,950 | 6,046 | 5,891 | 5,957 | -43 | -0.7% | 1,795,200 |
2024/02/27 | 5,936 | 6,059 | 5,926 | 6,000 | -8 | -0.1% | 2,673,300 |
2024/02/26 | 5,712 | 6,008 | 5,705 | 6,008 | +360 | +6.4% | 3,223,700 |
2024/02/22 | 5,855 | 5,882 | 5,288 | 5,648 | -242 | -4.1% | 5,166,600 |
2024/02/21 | 5,981 | 6,043 | 5,855 | 5,890 | +48 | +0.8% | 2,172,400 |
2024/02/20 | 5,797 | 5,921 | 5,765 | 5,842 | +63 | +1.1% | 1,860,000 |
2024/02/19 | 5,925 | 5,950 | 5,745 | 5,779 | -125 | -2.1% | 1,649,000 |
2024/02/16 | 5,798 | 5,972 | 5,793 | 5,904 | +199 | +3.5% | 3,169,000 |
2024/02/15 | 5,720 | 5,742 | 5,653 | 5,705 | +59 | +1% | 2,040,200 |
2024/02/14 | 5,700 | 5,743 | 5,623 | 5,646 | -76 | -1.3% | 2,128,700 |
2024/02/13 | 5,542 | 5,733 | 5,518 | 5,722 | +271 | +5% | 3,091,600 |
2024/02/09 | 5,444 | 5,550 | 5,421 | 5,451 | +31 | +0.6% | 3,591,300 |
251~
300
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
中外薬 | 862,000円 | +1.7% | +5.0% | 2.90% | 34.60倍 | 7.46倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
第一三共 | 370,200円 | +6.0% | +4.0% | 2.11% | 22.98倍 | 4.24倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
武 田 | 441,900円 | +7.7% | +206.9% | 4.44% | 59.10倍 | 1.00倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
大塚HD | 769,700円 | +2.2% | +10.2% | 1.56% | 14.78倍 | 1.48倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 145,800円 | +0.9% | +380.2% | 5.35% | 20.08倍 | 1.72倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム